Speeding up the evaluation of new agents in cancer

Mahesh K B Parmar1, Friederike M-S Barthel, Matthew Sydes

  • 1Clinical Trials Unit, London, UK. mp@ctu.mrc.ac.uk

Insights

New multi-arm, multi-stage clinical trial designs can accelerate the evaluation of novel treatments and reduce patient numbers. This approach efficiently tests multiple agents simultaneously using intermediate outcomes.

Area of Science:

  • Clinical trial methodology
  • Drug development and evaluation

Background:

  • Despite advances in biologic knowledge and drug development, the approval of new patient treatments has lagged.
  • Current standard trial designs face limitations in speed and efficiency for evaluating numerous new therapeutic agents.

Purpose of the Study:

  • To propose and present the multi-arm, multi-stage trial design as an innovative solution for faster and more efficient treatment evaluation.
  • To demonstrate the practical application of this novel trial methodology.

Main Methods:

  • Implementing a multi-arm, multi-stage trial design.
  • Utilizing intermediate outcomes to assess treatment efficacy.
  • Simultaneously testing multiple new agents and their combinations.

Main Results:

  • The proposed design requires fewer patients compared to standard trial designs.
  • Successfully applied the methodology in three distinct clinical trials.
  • Demonstrated increased efficiency in treatment evaluation.

Conclusions:

  • The multi-arm, multi-stage trial design offers a significant improvement in evaluating new treatments.
  • This methodology facilitates faster drug development and approval processes.
  • The presented trials showcase the viability and benefits of this innovative approach.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...